Furthermore, in PBMCs derived from a cohort of 18 SLE patients, stimulation of these PBMCs with phorbol 12-myristate 13-acetate and ionomycin displayed reduced IL-17 production after treatment with hydroxychloroquine (55). This evidence concerns the gene IL17A and systemic lupus erythematosus.